India says J&J withdraws proposal for speedy approval of Covid-19 vaccine

HEALTH-The U.S.-based company had said in April it was seeking an approval to conduct a bridging clinical study of its Janssen COVID-19 vaccine candidate in India. Trials in the United States at that time were paused on reports of rare blood clots./J&J-INDIA (UPDATE 1)UPDATE 1-India says J&J withdraws proposal for speedy vaccine approval

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/3zYA4u2
via IFTTT